1. Home
  2. SUPN vs CVCO Comparison

SUPN vs CVCO Comparison

Compare SUPN & CVCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$44.42

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

CVCO

Cavco Industries Inc. When Issued

HOLD

Current Price

$599.56

Market Cap

3.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUPN
CVCO
Founded
2005
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.5B
IPO Year
2010
1994

Fundamental Metrics

Financial Performance
Metric
SUPN
CVCO
Price
$44.42
$599.56
Analyst Decision
Strong Buy
Hold
Analyst Count
5
1
Target Price
$61.60
$550.00
AVG Volume (30 Days)
535.7K
134.5K
Earning Date
05-05-2026
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
15.79
EPS
N/A
23.98
Revenue
$392,755,000.00
$2,142,713,000.00
Revenue This Year
$22.70
$14.66
Revenue Next Year
$19.14
$7.70
P/E Ratio
N/A
$24.44
Revenue Growth
N/A
31.68
52 Week Low
$31.16
$395.37
52 Week High
$59.68
$713.01

Technical Indicators

Market Signals
Indicator
SUPN
CVCO
Relative Strength Index (RSI) 38.79 66.80
Support Level $43.67 $543.52
Resistance Level $52.36 $604.08
Average True Range (ATR) 1.41 22.16
MACD -0.01 4.00
Stochastic Oscillator 41.04 83.62

Price Performance

Historical Comparison
SUPN
CVCO

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

About CVCO Cavco Industries Inc. When Issued

Cavco Industries Inc designs and produces factory-built homes under the Cavco Homes, Fleetwood Homes, and Palm Harbor Homes brands. It also produces modular homes, park model homes, and vacation cabins, as well as commercial structures, among others. The company operates principally in two segments: Factory-built housing, which includes wholesale and retail systems-built housing operations, and the Financial services segment, which includes manufactured housing consumer finance and insurance. Cavco receives a majority of its revenue from the Factory-built housing segment.

Share on Social Networks: